European products

Listed below in alphabetic order are the brand names of Daiichi Sankyo Europe key products.

In Europe, the dissemination of information on prescription medicines is subject to strict legal regulation. Detailed information about such subjects as the mechanism or mode of action of our products may be provided only to medical professionals. For this reason, we can give only an overview about our leading products here.

Medical professionals can obtain more detailed information on our products by contacting the Medical Services department on medinfo@daiichi-sankyo.co.uk or on 01753 893600.

Trademark

Substance

Indication

Efient

Prasugrel

Atherothrombotic events

Sevikar

Olmesartan + Amlodipine

Hypertension

Sevikar HTC

Olmesartan + Amlodipine

Hydrochlorothiazide

Hypertension

Olmetec

Olmesartan

Hypertension

Olmetec Plus

Olmesartan + Hydrochlorotiazide

Hypertension

Evista

Raloxifen

Osteoporosis

Mevalotin*

Pravastatin

Hypercholesterolaemia

Podomexef*

Cefpodoxim

Respiratory tract infections

Lopresor*

Metoprolol

Hypertension

Lomir/Icaz*

Isradipin

Hypertension

Motifene

Diclofenac sodium

Pain relief

Prandin

Repaglinide

Type 2 diabetes

*These products are not marketed by Daiichi Sankyo in UK